PubRank

Alessandro Mathieu

Author PubWeight™ 44.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003 4.00
2 Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 2002 3.96
3 Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 2009 2.19
4 The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09. Rheumatology (Oxford) 2013 2.14
5 Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003 1.99
6 Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum 2004 1.89
7 Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol 2011 1.52
8 Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? Arthritis Care Res (Hoboken) 2012 1.46
9 Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006 1.21
10 The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev 2006 1.19
11 Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al. Arthritis Care Res (Hoboken) 2013 1.07
12 Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia. Arthritis Rheum 2007 1.05
13 Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford) 2011 1.04
14 Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients. Rheumatology (Oxford) 2012 1.03
15 A Sardinian patient with ankylosing spondylitis and HLA-B*2709 co-occurring with HLA-B*1403. Arthritis Rheum 2007 1.03
16 Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Autoimmun Rev 2012 0.98
17 Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region. Rheumatology (Oxford) 2010 0.96
18 Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum 2005 0.89
19 Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. Clin Exp Rheumatol 2011 0.86
20 Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study. Rheumatology (Oxford) 2010 0.85
21 Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis. Arthritis Rheum 2003 0.85
22 Vitamin D levels and potential impact in systemic sclerosis. Clin Exp Rheumatol 2011 0.82
23 The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept. Clin Exp Rheumatol 2011 0.81
24 Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies. Ann N Y Acad Sci 2007 0.81
25 Th17 and interleukin 23 in the pathogenesis of psoriatic arthritis and spondyloarthritis. J Rheumatol Suppl 2012 0.81
26 HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia. Arthritis Res Ther 2009 0.81
27 Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study. Joint Bone Spine 2011 0.81
28 Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issues. Clin Exp Rheumatol 2011 0.80
29 Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis. Drug Dev Res 2014 0.79
30 Etanercept in spondyloarthropathies. Part I: current evidence of efficacy. Clin Exp Rheumatol 2011 0.79
31 CD8+ T-cell mediated self-reactivity in HLA-B27 context as a consequence of dual peptide conformation. Clin Immunol 2010 0.78
32 The growing role of cardiac magnetic resonance imaging in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis. Semin Arthritis Rheum 2011 0.77
33 Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study. Clin Ther 2007 0.77
34 The origin of Behçet's disease geoepidemiology: possible role of a dual microbial-driven genetic selection. Clin Exp Rheumatol 2014 0.77
35 Osteoarthritis of the zygapophysial joints: efficacy of percutaneous radiofrequency neurotomy in the treatment of lumbar facet joint syndrome. Clin Exp Rheumatol 2012 0.76
36 Interaction pattern of Arg 62 in the A-pocket of differentially disease-associated HLA-B27 subtypes suggests distinct TCR binding modes. PLoS One 2012 0.76
37 HLA-B27 and free HLA class I heavy chains in ankylosing spondylitis. J Rheumatol 2003 0.75
38 Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests. Arthritis Res Ther 2013 0.75
39 HLA-B*2709 and spondylarthropathies: comment on the concise communication by Olivieri et al. Arthritis Rheum 2003 0.75
40 Multiple septic bursitis and spontaneous Achilles tendon tear in systemic lupus erythematosus. J Rheumatol 2010 0.75
41 Post-streptococcal reactive arthritis associated with group G streptococcal pharyngitis. J Clin Rheumatol 2010 0.75
42 Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice. BioDrugs 2014 0.75
43 The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis. Clin Exp Rheumatol 2014 0.75
44 Familial chilblain and late contractural arachnodactyly: a novel association? Joint Bone Spine 2009 0.75
45 Myocardial positron emission tomography/computed tomography scan revealing right coronary artery involvement in large vessel vasculitis. J Rheumatol 2012 0.75